Town & Country Bank & Trust CO dba First Bankers Trust CO lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 13.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,675 shares of the pharmacy operator’s stock after selling 1,950 shares during the quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Walgreens Boots Alliance were worth $701,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in WBA. NEXT Financial Group Inc grew its stake in Walgreens Boots Alliance by 27.8% during the 2nd quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock valued at $145,000 after purchasing an additional 580 shares during the last quarter. First National Bank of South Miami grew its position in Walgreens Boots Alliance by 3.0% in the second quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock worth $566,000 after acquiring an additional 303 shares during the period. Synovus Financial Corp grew its position in Walgreens Boots Alliance by 3.6% in the second quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock worth $883,000 after acquiring an additional 555 shares during the period. H D Vest Advisory Services purchased a new position in Walgreens Boots Alliance in the second quarter worth approximately $236,000. Finally, Cornerstone Advisors Inc. grew its position in Walgreens Boots Alliance by 131.6% in the second quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock worth $49,000 after acquiring an additional 508 shares during the period. 59.69% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance stock traded up $1.18 during midday trading on Friday, reaching $54.11. The company’s stock had a trading volume of 1,521,060 shares, compared to its average volume of 4,809,040. Walgreens Boots Alliance Inc has a fifty-two week low of $49.03 and a fifty-two week high of $86.31. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The company has a market cap of $47.04 billion, a P/E ratio of 8.99, a P/E/G ratio of 1.32 and a beta of 0.89. The business has a 50-day simple moving average of $53.03 and a 200-day simple moving average of $53.71.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares in the company, valued at $18,064,318.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.73% of the stock is owned by company insiders.
A number of research analysts recently issued reports on the company. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a report on Friday, August 23rd. Cleveland Research reiterated a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 2nd. Royal Bank of Canada lowered Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price for the company. in a report on Friday, September 27th. Finally, Deutsche Bank assumed coverage on Walgreens Boots Alliance in a report on Thursday, September 12th. They issued a “sell” rating for the company. Seven equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $62.24.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Conference Calls
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.